Global Spinal Muscular Atrophy Market is estimated to Witness High Growth owing to Opportunities in Gene Therapies
Spinal muscular atrophy (SMA) is a genetic disorder characterized by weakness and wasting (atrophy) of muscles due to the loss of motor neurons in the spinal cord and lower brain stem. It is caused by a mutation in the SMN1 gene and leads to loss of these motor neurons that control muscle movement and strength. Conventional drugs for managing SMA symptoms include glutamine, muscle relaxants,...
0 Комментарии 0 Поделились 1170 Просмотры 0 предпросмотр
Спонсоры